Calendar GSK plc Nyse

Equities

GSK

US37733W2044

Real-time Estimate Cboe BZX 01:21:28 07/05/2024 am IST 5-day change 1st Jan Change
43.42 USD -0.20% Intraday chart for GSK plc +4.19% +16.99%

Chart calendar GSK plc

a8e993.5bgiZ3ao7oI-7G8tzIZqEwDL5a1BkwVnNJmnUDfNQa0.0NBWSjD9vdtrpgVlqMMkRWmlsucG1Vw1UdPtInmgAP7c4EEeJOLW4VWnIg~353c6b28967ec62a33300c31005d5c2f

Upcoming events on GSK plc

08/05/2024 07:00 pm Annual General Meeting
31/07/2024 11:30 am Q2 2024 Earnings Release
30/10/2024 11:30 am Q3 2024 Earnings Release
05/02/2025 12:30 pm Q4 2024 Earnings Release
30/04/2025 Q1 2025 Earnings Release (Projected)
23/07/2025 Q2 2025 Earnings Release (Projected)
29/10/2025 Q3 2025 Earnings Release (Projected)
11/02/2026 Q4 2025 Earnings Release (Projected)

Past events on GSK plc

01/05/2024 04:30 pm Q1 2024 Earnings Call
01/05/2024 11:30 am Q1 2024 Earnings Release
30/04/2024 European Society of Clinical Microbiology and Infectious Diseases Meeting
26/03/2024 07:30 pm BNP Exane Healthcare Conference
19/03/2024 06:30 pm Investor Meeting - ESG
19/03/2024 Berenberg UK Corporate Conference
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02819
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03095
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01988
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03157
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03080
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 00621
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01462
07/03/2024 01:21 am Retroviruses and Opportunistic Infection Conference - Poster No 03579
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01012
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03038
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02263
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01838
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01783
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03110

Past dividends on GSK plc

22/02/2024 Final Payment 0.16 GBP
16/11/2023 Interim Payment 0.14 GBP
17/08/2023 Interim Payment 0.14 GBP
18/05/2023 Interim Payment 0.14 GBP
23/02/2023 Final Payment 0.1375 GBP
17/11/2022 Interim Payment 0.1375 GBP
18/08/2022 Interim Payment 0.1625 GBP
18/07/2022 0 GBP
19/05/2022 Interim Payment 0.14 GBP
24/02/2022 Final Payment 0.23 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP
Released
Forecast
Spread
33 754
33 382
1.11%
34 099
34 076
0.07%
34 114
34 029
0.25%
29 324
29 105
0.75%
30 328
29 850
1.6%

31 583

EBITDA
Million GBP
Released
Forecast
Spread
11 968
11 155
7.28%
9 530
10 575
-9.88%
11 330
10 048
12.76%
10 449
9 257
12.88%
11 635
10 203
14.04%

10 582

EBIT
Million GBP
Released
Forecast
Spread
8 972
9 182
-2.29%
8 906
8 955
-0.55%
8 806
8 717
1.02%
8 151
7 952
2.5%
8 786
8 780
0.07%

9 169

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
6 221
5 926
4.97%
6 968
6 763
3.02%
5 442
5 794
-6.07%
5 628
5 548
1.45%
6 064
7 498
-19.12%

7 435

Net income
Million GBP
Released
Forecast
Spread
4 645
4 026
15.38%
5 749
4 894
17.46%
4 385
3 990
9.91%
14 956
6 238
139.74%
4 928
5 481
-10.09%

5 586

EPS
GBP
Released
Forecast
Spread
1,16
1,06
9.69%
1,43
1,21
17.91%
1,08
1,02
6.28%
3,66
1,66
120.52%
1,22
1,38
-11.61%

1,37

Announcement Date05/02/2003/02/2109/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million GBP
Released
Forecast
Spread
9 780
9 145
6.94%
6 929
6 906
0.33%
7 829
7 214
8.52%
7 376
7 101
3.88%
6 951
6 580
5.64%
7 178
6 795
5.63%
8 147
7 727
5.43%
8 052
7 621
5.65%
7 363
7 060
4.3%

7 525


8 557


8 216


7 590


7 865

EBITDA
Million GBP
Released
Forecast
Spread
3 317
2 850
16.4%
2 639
2 138
23.45%
3 561
2 704
31.68%
1 602
1 855
-13.63%
2 732
2 418
12.97%
2 622
2 506
4.64%
3 351
3 072
9.09%
2 930
2 094
39.93%
2 992
2 406
24.36%

2 595


3 095


1 836







EBIT
Million GBP
Released
Forecast
Spread
2 613
2 291
14.06%
2 008
1 740
15.4%
2 605
2 264
15.08%
1 595
1 509
5.7%
2 092
1 930
8.42%
2 170
1 999
8.56%
2 772
2 570
7.88%
1 752
1 836
-4.58%
2 443
2 099
16.38%

2 209


2 809


1 778


2 408


2 487

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
2 598
2 268
14.55%
896
1 243
-27.89%
1 012
1 860
-45.59%
1 626
946
71.97%
1 907
1 529
24.72%
1 987
1 500
32.51%
1 791
2 225
-19.51%
379
1 361
-72.15%
1 355
1 696
-20.11%

1 825


2 487


1 506







Net income
Million GBP
Released
Forecast
Spread
1 802
1 674
7.66%
975
802
21.54%
10 315
1 356
660.76%
1 495
1 151
29.9%
1 490
1 179
26.41%
1 624
1 213
33.86%
1 464
1 739
-15.79%
350
834
-58.04%
1 046
1 297
-19.32%

1 426


1 877


1 266







EPS
GBP
Released
Forecast
Spread
0,45
0,41
8.83%
0,21
0,21
-3.22%
2,52
0,34
640.73%
0,37
0,19
95.19%
0,37
0,29
27.52%
0,40
0,30
35.52%
0,36
0,43
-15.26%
0,09
0,20
-58.02%
0,25
0,31
-19.17%

0,34


0,45


0,30







Announcement Date27/04/2227/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/2401/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW